New Jersey Senate Bill S3427

New Jersey 2022-2023 Regular Session

• Introduced: 12/19/22
• Refer: 12/19/22

Caption

Requires private health insurers, SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover wigs under certain circumstances.

Impact

The bill specifically amends existing insurance regulations related to durable medical equipment, establishing that wigs be categorized and treated similarly. Under the provisions of this bill, subscribers will be eligible for coverage for a wig once every 36 months, aligning wig expenses with other reimbursable durable medical equipment. This coverage is notable as it broadens the criteria for obtaining a wig, going beyond current limitations that primarily cover individuals undergoing chemotherapy for cancer. Previously, the SHBP and SEHBP provided limited coverage for wigs exclusively for such cancer patients, and neither the state Medicaid program nor NJ FamilyCare provided any coverage at all. Thus, the bill significantly enhances access to necessary medical products for those dealing with various health issues, including alopecia and other medical conditions.

Summary

Senate Bill 3427 requires private health insurance plans, the State Health Benefits Program (SHBP), the School Employees Health Benefits Program (SEHBP), as well as state Medicaid and NJ FamilyCare programs, to cover expenses associated with the purchase of wigs for individuals with medical conditions resulting in hair loss. Coverage is available under specific circumstances: a wig must be prescribed by a licensed medical professional, including dermatologists and oncologists, and certified as medically necessary for treatment or rehabilitation related to a diagnosed illness or chronic condition. The bill aims to ensure that individuals do not face barriers in accessing wigs, which are deemed essential for emotional and psychological well-being during treatment.

Contention

While the intent of SB 3427 is broadly seen as beneficial to enhancing healthcare coverage for medical needs, it also raises questions about insurance policy costs and the potential for increased administration burdens on insurance providers. Proponents argue that this represents a necessary adjustment to contemporary healthcare needs and expectations. However, concerns may be voiced regarding the implications for insurers regarding cost management and policy implementation. Additionally, the necessity of identifying medical need through documentation may introduce complexities in access to these benefits. The ongoing discussions regarding the management of health insurance costs may frame part of the debate surrounding the adoption of this bill.